Australia markets open in 2 hours 52 minutes

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
20.36+0.09 (+0.44%)
At close: 04:00PM EDT
20.36 0.00 (0.00%)
After hours: 04:01PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-396,567
-351,511
-225,334
-152,142
-128,389
Depreciation & amortisation
5,236
4,903
2,731
397
177
Stock-based compensation
47,174
38,780
23,941
10,521
8,311
Change in working capital
628
28,064
15,541
17,707
343
Accounts payable
-1,964
-763
7,278
1,417
607
Other working capital
-340,758
-293,187
-178,546
-117,802
-71,819
Other non-cash items
20,634
-6,874
694
2,445
2,396
Net cash provided by operating activities
-340,133
-293,187
-178,546
-117,802
-70,720
Cash flows from investing activities
Investments in property, plant and equipment
-3,018
-3,954
-10,503
-18,892
-1,099
Purchases of investments
-1,081,292
-887,737
-425,158
-
0
Sales/maturities of investments
842,260
502,857
-
-
-
Net cash used for investing activities
-242,050
-388,834
-435,661
-18,892
-1,099
Cash flows from financing activities
Common stock issued
-
238,263
328,251
0
60,058
Other financing activities
30,964
37,102
30,895
440,835
-
Net cash used provided by (used for) financing activities
619,821
623,191
423,602
440,835
60,058
Net change in cash
37,638
-58,830
-190,605
304,141
-11,761
Cash at beginning of period
140,085
197,218
387,823
83,682
95,443
Cash at end of period
177,723
138,388
197,218
387,823
83,682
Free cash flow
Operating cash flow
-340,133
-293,187
-178,546
-117,802
-70,720
Capital expenditure
-3,018
-3,954
-10,503
-18,892
-1,099
Free cash flow
-340,758
-293,187
-178,546
-117,802
-71,819